The vitamin biomarkers market is projected to grow from USD 4.0 billion in 2025 to USD 11.7 billion by 2035, at a CAGR of 11.3%. Analyzers will dominate with a 47.6% market share, while serum retinol (vitamin a) will lead the biomarker type segment with a 18.4% share.